Novorapid and Melatonin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Novorapid (insulin aspart recombinant) and Melatonin (melatonin). Common drug interactions include musculoskeletal pain among females and abdominal distension among males.
The phase IV clinical study analyzes what interactions people have when they take Novorapid and Melatonin. It is created by eHealthMe based on reports of 205 people who take the same drugs from the FDA, and is updated regularly.
What is Novorapid?
Novorapid has active ingredients of insulin aspart recombinant. It is often used in type 1 diabetes. eHealthMe is studying from 24,730 Novorapid users. Check the latest studies of Novorapid.
What is Melatonin?
Melatonin has active ingredients of melatonin. It is often used in insomnia. eHealthMe is studying from 56,212 Melatonin users. Check the latest studies of Melatonin.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
205 people who take Novorapid and Melatonin together, and have interactions are studied.
What are the common drug interactions of Novorapid and Melatonin, by gender? *
What are the common drug interactions of Novorapid and Melatonin, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Novorapid and Melatonin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Novorapid and Melatonin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Novorapid:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Melatonin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Novorapid and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Melatonin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on insulin aspart recombinant and melatonin (the active ingredients of Novorapid and Melatonin, respectively), and Novorapid and Melatonin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Glyburide cause Digoxin Toxicity? - 3 seconds ago
- High Blood Pressure and Vomiting Aggravated - 4 seconds ago
- High Blood Cholesterol in Mirtazapine, how severe and when it was recovered? - 19 seconds ago
- Cosopt and Gastroesophageal Reflux Disease for Women aged 60+ - 22 seconds ago
- Cosopt and Gastrooesophageal Reflux Disease for Women aged 60+ - 22 seconds ago
- Cosopt and Gastro-Oesophageal Reflux Disease for Women aged 60+ - 22 seconds ago
- Cosopt and Reflux for Women aged 60+ - 23 seconds ago
- Cosopt and Heartburn for Women aged 60+ - 23 seconds ago
- Cosopt and Non-Cardiac Chest Pain for Women aged 60+ - 23 seconds ago
- Cosopt and Gerds for Women aged 60+ - 23 seconds ago